Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed

European Journal of Pharmacology

Volumn 418, Issue 1-2, 2001, Pages 117-125

  Ralevic, Vera ^a   Kendall, David A ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NONE

Author keywords

Cannabinoid; Cardiovascular system; Mesenteric artery; Sensory neurotransmission

Indexed keywords

4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CALCITONIN; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; DEXANABINOL; RIMONABANT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSTIMULATION; MALE; MESENTERIC ARTERY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; VASODILATATION;

ADENOSINE DIPHOSPHATE; ANIMALS; BENZOFURANS; BORNANES; CALCITONIN GENE-RELATED PEPTIDE; CANNABINOIDS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; MALE; MESENTERIC ARTERIES; NEURONS, AFFERENT; NITROPRUSSIDE; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SYNAPTIC TRANSMISSION; TETRAHYDROCANNABINOL; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 0035917641     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00940-2     Document Type: Article

References (45)

1. Cannabinoids control spasticity and tremor in a multiple sclerosis model
2. A selective inverse agonist for central cannabinoid receptors inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1: Evidence for a new model of receptor/ligand interactions
3. 1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal neurones in the rat
4. 1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries
5. Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine
6. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
7. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
8. 2 receptors
9. Neurogenic vasodilation and release of calcitonin gene-related peptide (CGRP) from perivascular nerves in the rat mesenteric artery
10. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
11. Inhibition of periarterial nerve stimulation-induced vasodilation of the mesenteric arterial bed by CGRP (8-37) and CGRP receptor desensitization
12. 1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study
13. Cannabinoid receptors undergo axonal flow in sensory nerves
14. Liquid chromatographic-mass spectrometric measurement of the endogenous cannabinoid 2-arachidonylglycerol in the spinal cord and peripheral nervous system
15. 1 receptors on peripheral sympathetic nerves
16. 2+-induced relaxation
17. 2 receptors
18. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat
19. Adrenergic modulation of calcitonin gene-related peptide (CGRP)-containing nerve-mediated vasodilation in the rat mesenteric resistance vessel
20. NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries
21. Cardiovascular effects of anandamide in anaesthetized and conscious normotensive and hypertensive rats
22. Differential effects of neuropeptide Y and opioids on neurogenic responses of the perfused rat mesentery
23. 2 receptors
24. The sensory-efferent function of capsaicin-sensitive nerves
25. 1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat
26. Pharmacological characterization of presynaptic calcitonin gene-related peptide (CGRP) receptors on CGRP-containing vasodilator nerves in rat mesenteric resistance arteries
27. 1 cannabinoid receptor activity
28. The evidence for the existence of cannabinoid receptors
29. 1 cannabinoid receptors
30. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
31. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine
32. Cannabinoid modulation of capsaicin-sensitive primary afferent neurotransmission in the rat isolated mesenteric arterial bed
33. Prejunctional modulation of sensory-motor nerve mediated vasodilatation of the rat mesenteric arterial bed by opioid peptides
34. Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed
35. Endocannabinoids: A new class of vasoactive substances
36. An endogenous cannabinoid as an endothelium-derived vasorelaxant
37. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
38. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: Implications for antinociception
39. 1 subtype
40. Mechanisms of cannabinoid receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons
41. 1 cannabinoid receptor in the hypotensive action of anandamide
42. The neurobiology of cannabinoid analgesia
43. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery
44. The actions of the cannabinoid receptor antagonist, SR141716A, in the rat isolated mesenteric artery
45. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide